As of 5 Jul 2026, Vimta Labs share price is ₹586.00. The stock opened at ₹591.70, compared to its previous close of ₹586.65. During today's trading session, Vimta Labs share price moved in the range of ₹580.35 to ₹599.00, with an average price of ₹589.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹376.05 and a high of ₹902.65. On the performance front, Vimta Labs share price has declined by 4.06% over the last six months and is up 23.20% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Revenue | ₹318.26 | ₹318.19 | ₹278.28 | ₹210.68 |
| Other Income | ₹4.01 | ₹3.44 | ₹1.45 | ₹0.83 |
| Total Revenue | ₹322.27 | ₹321.63 | ₹279.73 | ₹211.51 |
| Total Expenses | ₹267.79 | ₹256.64 | ₹222.82 | ₹182.97 |
| Profit Before Tax | ₹54.48 | ₹65.00 | ₹55.69 | ₹28.54 |
| Tax | ₹13.47 | ₹16.83 | ₹14.36 | ₹7.14 |
| Profit After Tax | ₹41.01 | ₹48.17 | ₹41.33 | ₹21.41 |
| EPS - Basic | ₹18.51 | ₹21.77 | ₹18.70 | ₹9.68 |
| EPS - Diluted | ₹18.24 | ₹21.35 | ₹18.32 | ₹9.68 |
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Profit before tax | ₹54.48 | ₹65.00 | ₹55.69 | ₹28.54 |
| Income before WC changes | ₹91.75 | ₹104.11 | ₹87.07 | ₹57.77 |
| Change in Assets | -₹11.53 | -₹15.46 | -₹15.26 | -₹19.81 |
| Change in Liabilities | -₹3.85 | ₹11.82 | ₹3.90 | ₹6.43 |
| Change in WC | -₹15.38 | -₹3.64 | -₹11.36 | -₹13.38 |
| Cash flow from Operations | ₹60.89 | ₹87.94 | ₹59.07 | ₹37.18 |
| Cash flow from Investing | -₹76.05 | -₹57.26 | -₹37.85 | -₹31.92 |
| Cash flow from Financing | -₹1.90 | -₹10.98 | -₹16.61 | -₹4.57 |
| Total Cash Flow | -₹17.06 | ₹19.70 | ₹4.61 | ₹0.69 |
| Cash (Start of the year) | ₹30.50 | ₹10.80 | ₹6.19 | ₹5.51 |
| Cash (End of the year) | ₹13.44 | ₹30.50 | ₹10.80 | ₹6.19 |
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Non-Current Assets | ₹242.45 | ₹198.67 | ₹182.84 | ₹163.82 |
| Current Assets | ₹157.60 | ₹163.66 | ₹124.36 | ₹110.54 |
| Total Assets | ₹400.05 | ₹362.33 | ₹307.20 | ₹274.36 |
| Current Liabilities | ₹54.07 | ₹57.28 | ₹47.75 | ₹53.91 |
| Net Current Asset | ₹103.53 | ₹106.38 | ₹76.61 | ₹56.63 |
| Non-Current Liabilities | ₹26.28 | ₹23.26 | ₹25.47 | ₹26.06 |
| Equity Capital | ₹319.70 | ₹281.79 | ₹233.98 | ₹194.38 |
| Total Equity & Liabilities | ₹400.05 | ₹362.33 | ₹307.20 | ₹274.36 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹407.29 | ₹343.98 | ₹288.60 | ₹315.12 |
| Other Income | ₹8.99 | ₹4.24 | ₹3.71 | ₹3.47 |
| Total Revenue | ₹416.28 | ₹348.22 | ₹292.31 | ₹318.58 |
| Total Expenses | ₹310.71 | ₹259.22 | ₹229.80 | ₹254.75 |
| Profit Before Tax | ₹103.95 | ₹89.00 | ₹62.50 | ₹63.83 |
| Tax | ₹26.44 | ₹22.25 | ₹13.69 | ₹16.53 |
| Profit After Tax | ₹77.51 | ₹66.76 | ₹48.81 | ₹47.30 |
| EPS - Basic | ₹17.40 | ₹30.28 | ₹18.51 | ₹21.37 |
| EPS - Diluted | ₹17.20 | ₹29.86 | ₹18.24 | ₹20.96 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹103.95 | ₹90.41 | ₹54.48 | ₹63.83 |
| Income before WC changes | ₹154.65 | ₹124.06 | ₹91.75 | ₹102.74 |
| Change in Assets | -₹7.75 | -₹25.01 | -₹11.53 | -₹15.45 |
| Change in Liabilities | ₹23.91 | ₹17.02 | -₹3.85 | ₹11.45 |
| Change in WC | ₹16.16 | -₹7.99 | -₹15.38 | -₹3.99 |
| Cash flow from Operations | ₹147.14 | ₹94.05 | ₹60.89 | ₹86.51 |
| Cash flow from Investing | -₹129.67 | -₹75.54 | -₹76.05 | -₹56.93 |
| Cash flow from Financing | -₹10.35 | -₹16.12 | -₹1.90 | -₹10.66 |
| Total Cash Flow | ₹7.12 | ₹2.40 | -₹17.06 | ₹18.92 |
| Cash (Start of the year) | ₹15.84 | ₹13.44 | ₹30.50 | ₹10.65 |
| Cash (End of the year) | ₹22.97 | ₹15.84 | ₹13.44 | ₹29.57 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹337.36 | ₹278.72 | ₹236.87 | ₹197.69 |
| Current Assets | ₹224.87 | ₹187.82 | ₹157.60 | ₹162.78 |
| Total Assets | ₹562.23 | ₹466.53 | ₹394.47 | ₹360.47 |
| Current Liabilities | ₹65.52 | ₹64.37 | ₹54.07 | ₹56.74 |
| Net Current Asset | ₹159.35 | ₹123.45 | ₹103.53 | ₹106.03 |
| Non-Current Liabilities | ₹39.83 | ₹23.32 | ₹26.28 | ₹23.15 |
| Equity Capital | ₹456.87 | ₹378.85 | ₹314.12 | ₹280.58 |
| Total Equity & Liabilities | ₹562.23 | ₹466.53 | ₹394.47 | ₹360.47 |
Vimta Labs Limited is contract research and testing services provider in India. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include drug discovery, development, and drug life cycle management support services; preclinical research and testing services for medical device companies; contract research and testing for agrochemical and specialty chemical companies; food testing and analytical development services to support manufacturers, processors, farmers, and retailers; and environmental regulatory services, such as impact assessments and post project monitoring to various industries, such as power, infrastructure, and others.
Vimta Labs share price is ₹586.00 as on 03 Jul, 2026, 15:29 IST.
In the last 1 year, Vimta Labs delivered a return of 23.20%. The Vimta Labs share price hit a high of ₹902.65 and low of ₹376.05.
The Mutual Fund Shareholding in Vimta Labs was 0.00% at the end of Mar 2026.
The 52-week high and low of Vimta Labs share is ₹902.65 and ₹376.05 as of 03 Jul, 2026.
The market capitalisation of Vimta Labs is ₹2,137.65 Crores as on 03 Jul, 2026.
The stock symbol of Vimta Labs is VIMTALABS on the NSE, 524394 on the BSE, and the ISIN is INE579C01029.
Vimta Labs shares closed yesterday at ₹586.65 on NSE & ₹586.10 on BSE
To buy Vimta Labs shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of Vimta Labs or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Vimta Labs shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of Vimta Labs is 34.83 and 6.24 respectively, as on 03 Jul, 2026, 15:29 IST.